Correction: A consensus molecular subtypes classification strategy for clinical colorectal cancer tissues

Results Section

- Table 1: Column “Public ID” of the last row “FFPE-RNA application cohort” reads NA.

○ Should read: GSE267010.

- Title of Figure 3: Mutations characteristics of the CMSs in the FFPE application cohort.

○ Should read: Molecular characteristics of the CMSs in the FFPE application cohort.

- Paragraph “Molecular characteristics of the CMSs in the FFPE-RNA application cohort,” third sentence, reads: Next, we assessed gene set enrichment across the CMSs and could recover all previously reported iCMS features (Fig 3B).

○ Should read: Next, we assessed gene set enrichment across the CMSs and could recover all previously reported CMS features (Fig 3B).

Discussion Section

- Fourth paragraph, last sentence, reads: “Hence, the observed OS patterns appear as intrinsic feature of the selected patient group and further strengthen the robustness of the CMSFFPE classifier.”

○ Should read: “Hence, the observed OS patterns appear as intrinsic features of the selected patient group and further strengthen the robustness of the CMSFFPE classifier.”

Materials and Methods Section

- Paragraph “RNA-sequencing and targeted exome sequencing,” third paragraph, first sentence, reads: “The TSO500 High-Throughput assay was performed on genomic DNA of the FFPE-RNA application cohort as instructed by IlluminaPaired-end …”

○ Should read: “The TSO500 High-Throughput assay was performed on genomic DNA of the FFPE-RNA application cohort as instructed by Illumina. Paired-end …”

Footnotes

• ↵* Tim R de Back and Tan Wu are shared first authorship

• ↵† Dirkje W Sommeijer, Xin Wang, and Louis Vermeulen are shared senior authorship